Streetbeat News

Products Services

PBR

Brazil's state-run oil company Petrobras has announced that it will increase gasoline prices by 0.41 real to 2.93 reais per liter and diesel prices by 0.78 real to 3.80 reais per liter starting Wednesday.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:08 pm

CYBN

Cybin Inc. has been granted a U.S. patent for its proprietary deuterated psilocybin analog in the CYB003 program. The patent covers composition of matter claims and treatment methods until 2041. The company's intellectual property portfolio now includes 2 granted U.S. patents and over 50 pending patent applications across 6 patent families. CYB003 is currently being evaluated in a Phase 2 clinical trial for the treatment of major depressive disorder. The company expects to report topline Phase 2 efficacy data for CYB003 in Q3/Q4 2023.

Portfolio Pulse from Happy Mohamed

August 15, 2023 | 12:00 pm

SXTP

60 Degrees Pharmaceuticals has registered a Phase IIB study of Tafenoquine for the treatment of COVID-19 on ClinicalTrials.gov. The study is named ACLR8-LR.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:32 am

GLTO

Galecto has announced the topline results from its Phase 2b GALACTIC-1 trial of GB0139 for Idiopathic Pulmonary Fibrosis. The trial did not meet its primary endpoint, leading the company to plan to discontinue the development of GB0139.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:32 am

DCTH

Delcath Systems announced that the FDA has approved its HEPZATO KIT for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma. Following the announcement, the company's shares surged by 69% in premarket trading.

Portfolio Pulse from Charles Gross

August 15, 2023 | 11:12 am

F

Actor Dwayne Johnson, also known as the Rock, has purchased a new Ford F-150 Raptor R from Galpin Ford in California. The event was attended by Ford's CEO, Jim Farley. The Ford F-150 Raptor R is a high-performance, gasoline-powered truck that offers 700 horsepower and 640 lb-ft of torque. It shares the same exterior design as the Raptor but offers better performance with a 5.2 liter V-8 engine previously used in the Ford Mustang Shelby GT500.

Portfolio Pulse from Anan Ashraf

August 15, 2023 | 11:07 am

GRTS

Gritstone Bio has entered into a multi-year agreement with Genevant Sciences for a non-exclusive license under Genevant's LNP technology. The license will be used on a pathogen-by-pathogen basis for self-amplifying RNA vaccines.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:06 am

EVGO

RIVN

EVgo has announced that Rivian's R1T and R1S models have joined the list of compatible vehicles for its Autocharge+ service. This will allow Rivian vehicle owners to automatically start charging their vehicles at any EVgo station without needing a membership card or mobile app.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:03 am

TLSA

The FDA has cleared Tiziana Life Sciences' Investigational New Drug Application for intranasal Foralumab to be studied in Alzheimer's disease. This is a significant step for Tiziana Life Sciences as it allows the company to proceed with clinical trials.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:03 am

FOLD

Amicus Therapeutics has announced the approval and launch of its new Pompe disease therapy in the United Kingdom. This could potentially increase the company's market share and revenues.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:02 am